The EXOs of AD patients may contain more inhibitory compounds TGF-β, PD-1 and cytotoxic T lymphocyte antigen 4 (CTLA-4) and cyclooxygenase 2 (COX2) [133–135]. The gene discussed is PTGS2; the disease is Alzheimer disease.